Fontan F, Baudet E. Surgical repair of tricuspid atresia. Thorax. 1971;26(3):240–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pundi KN, Johnson JN, Dearani JA, Pundi KN, Li Z, Hinck CA, Dahl SH, Cannon BC, O’Leary PW, Driscoll DJ, et al. 40-Year Follow-Up after the Fontan Operation: long-term outcomes of 1,052 patients. J Am Coll Cardiol. 2015;66(15):1700–10.

Article  PubMed  Google Scholar 

d’Udekem Y, Iyengar AJ, Galati JC, Forsdick V, Weintraub RG, Wheaton GR, Bullock A, Justo RN, Grigg LE, Sholler GF, et al. Redefining expectations of long-term survival after the Fontan procedure: twenty-five years of follow-up from the entire population of Australia and New Zealand. Circulation. 2014;130(11 Suppl 1):S32–38.

PubMed  Google Scholar 

Rychik J, Atz AM, Celermajer DS, Deal BJ, Gatzoulis MA, Gewillig MH, Hsia TY, Hsu DT, Kovacs AH, McCrindle BW et al. Evaluation and management of the child and adult with Fontan circulation: a Scientific Statement from the American Heart Association. Circulation. 2019:CIR0000000000000696.

Tellez L, Rodriguez de Santiago E, Albillos A. Fontan-Associated Liver Disease: pathophysiology, staging, and management. Semin Liver Dis. 2021;41(4):538–50.

Article  CAS  PubMed  Google Scholar 

Emamaullee J, Zaidi AN, Schiano T, Kahn J, Valentino PL, Hofer RE, Taner T, Wald JW, Olthoff KM, Bucuvalas J, et al. Fontan-Associated Liver Disease: Screening, Management, and transplant considerations. Circulation. 2020;142(6):591–604.

Article  PubMed  PubMed Central  Google Scholar 

Sganga D, Hollander SA, Vaikunth S, Haeffele C, Bensen R, Navaratnam M, McDonald N, Profita E, Maeda K, Concepcion W, et al. Comparison of combined heart–liver vs heart-only transplantation in pediatric and young adult Fontan recipients. J Heart Lung Transpl. 2021;40(4):298–306.

Article  Google Scholar 

Amdani S, Simpson KE, Thrush P, Shih R, Simmonds J, Knecht K, Mogul DB, Hurley K, Koehl D, Cantor R, et al. Hepatorenal dysfunction assessment with the Model for End-Stage Liver Disease excluding INR score predicts worse survival after heart transplant in pediatric Fontan patients. J Thorac Cardiovasc Surg. 2022;163(4):1462–e14731412.

Article  PubMed  Google Scholar 

Hofferberth SC, Singh TP, Bastardi H, Blume ED, Fynn-Thompson F. Liver abnormalities and post-transplant survival in pediatric Fontan patients. Pediatr Transplant. 2017;21(8).

Simpson KE, Esmaeeli A, Khanna G, White F, Turnmelle Y, Eghtesady P, Boston U, Canter CE. Liver cirrhosis in Fontan patients does not affect 1-year post-heart transplant mortality or markers of liver function. J Heart Lung Transplant. 2014;33(2):170–7.

Article  PubMed  Google Scholar 

Emamaullee J, Khan S, Weaver C, Goldbeck C, Yanni G, Kohli R, Genyk Y, Zhou SM, Shillingford N, Sullivan PM et al. Non-invasive biomarkers of Fontan-associated liver disease. Jhep Rep. 2021;3(6).

Wu FM, Jonas MM, Opotowsky AR, Harmon A, Raza R, Ukomadu C, Landzberg MJ, Singh MN, Valente AM, Egidy Assenza G, et al. Portal and centrilobular hepatic fibrosis in Fontan circulation and clinical outcomes. J Heart Lung Transpl. 2015;34(7):883–91.

Article  Google Scholar 

Elder RW, McCabe NM, Veledar E, Kogon BE, Jokhadar M, Rodriguez FH, McConnell ME, Book WM. Risk factors for major adverse events late after fontan palliation. Congenit Heart Dis. 2015;10(2):159–68.

Article  PubMed  Google Scholar 

Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.

Article  PubMed  PubMed Central  Google Scholar 

Wells G, Shea B, O’Connell D, Peterson j, Welch V, Losos M, Tugwell P. The Newcastle–Ottawa Scale (NOS) for Assessing the Quality of Non-Randomized Studies in Meta-Analysis. 2000;4447.

Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557–60.

Article  PubMed  PubMed Central  Google Scholar 

Emamaullee J, Martin S, Goldbeck C, Rocque B, Barbetta A, Kohli R, Starnes V. Evaluation of Fontan-associated liver disease and ethnic disparities in long-term survivors of the Fontan Procedure: a Population-based study. Annals of surgery; 2022.

Pundi K, Pundi KN, Kamath PS, Cetta F, Li Z, Poterucha JT, Driscoll DJ, Johnson JN. Liver disease in patients after the Fontan Operation. Am J Cardiol. 2016;117(3):456–60.

Article  PubMed  Google Scholar 

Wu FM, Ukomadu C, Odze RD, Valente AM, Mayer JE Jr., Earing MG. Liver disease in the patient with Fontan circulation. Congenit Heart Dis. 2011;6(3):190–201.

Article  PubMed  Google Scholar 

Munsterman ID, Duijnhouwer AL, Kendall TJ, Bronkhorst CM, Ronot M, van Wettere M, van Dijk APJ, Drenth JPH, Tjwa E, Nijmegen Fontan I. The clinical spectrum of Fontan-associated liver disease: results from a prospective multimodality screening cohort. Eur Heart J. 2019;40(13):1057–68.

Article  CAS  PubMed  Google Scholar 

Silva-Sepulveda JA, Fonseca Y, Vodkin I, Vaughn G, Newbury R, Vavinskaya V, Dwek J, Perry JC, Reshamwala P, Baehling C, et al. Evaluation of Fontan liver disease: correlation of transjugular liver biopsy with magnetic resonance and hemodynamics. Congenit Heart Dis. 2019;14(4):600–8.

Article  PubMed  Google Scholar 

Evans WN, Acherman RJ, Ciccolo ML, Carrillo SA, Galindo A, Rothman A, Winn BJ, Yumiaco NS, Restrepo H. MELD-XI scores correlate with Post-fontan hepatic biopsy fibrosis scores. Pediatr Cardiol. 2016;37(7):1274–7.

Article  PubMed  Google Scholar 

Lewis MJ, Reardon LC, Aboulhosn J, Haeffele C, Chen S, Kim Y, Fuller S, Forbess L, Alshawabkeh L, Urey MA, et al. Morbidity and mortality in adult Fontan patients after Heart or Combined Heart-Liver transplantation. J Am Coll Cardiol. 2023;81(22):2161–71.

Article  PubMed  Google Scholar 

Griffiths ER, Lambert LM, Ou Z, Shaaban A, Rezvani M, Carlo WF, Schumacher KR, DiPaola F, O’Connor MJ, Nandi D et al. Fontan-associated liver disease after heart transplant. Pediatr Transplant. 2022;27(2).

Kramer P, Schleiger A, Schafstedde M, Danne F, Nordmeyer J, Berger F, Ovroutski S. A Multimodal score accurately classifies Fontan failure and late mortality in adult Fontan patients. Front Cardiovasc Med. 2022;9.

Mendel B, Christianto, Setiawan M, Siagian SN, Prakoso R. Pharmacology Management in improving Exercise Capacity of patients with Fontan circulation: a systematic review and Meta-analysis. Curr Cardiol Rev. 2022;18(5).

Lewis MJ, Reardon LC, Aboulhosn J, Haeffele C, Chen S, Kim Y, Fuller S, Forbess L, Alshawabkeh L, Urey MA, et al. Clinical outcomes of adult Fontan-Associated Liver Disease and Combined Heart-Liver transplantation. J Am Coll Cardiol. 2023;81(22):2149–60.

Article  PubMed  Google Scholar